Source:http://linkedlifedata.com/resource/pubmed/id/16365447
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2005-12-20
|
pubmed:abstractText |
Streptococcus pneumoniae causes serious infections in children, the elderly, and immunocompromised patients. Protection against infections with S. pneumoniae is mediated through Abs against the capsular polysaccharides (caps-PS). We previously showed that the murine Ab response to caps-PS is dependent on CD40-CD40L interaction. In the present paper, we addressed the question of whether the CD40-CD40L-mediated modulation of the anti-caps-PS immune reaction is the result of a direct interaction between B lymphocytes and T lymphocytes or of an indirect interaction. SCID/SCID mice reconstituted with B lymphocytes from wild-type mice did not mount anti-caps-PS Abs. SCID/SCID mice reconstituted with B lymphocytes from wild-type mice and CD4+ T lymphocytes from wild-type mice but not CD4+ T lymphocytes from CD40L knockout mice stimulated the anti-caps-PS Ab response. This indicated that CD4+ T lymphocytes stimulated the anti-caps-PS Ab response in a CD40L-dependent manner. SCID/SCID mice reconstituted with B lymphocytes from CD40 knockout mice and CD4+ T lymphocytes from wild-type mice generated an anti-caps-PS Ab response that could be inhibited by MR1, a blocking anti-CD40L Ab. These data indicated that CD4+ T lymphocytes stimulated the anti-caps-PS Ab response in an indirect way. Finally, lethally irradiated CD40 knockout mice reconstituted with bone marrow from wild-type mice mounted an anti-caps-PS Ab response that was comparable to the Ab response in wild-type mice, revealing that the required CD40 was on hemopoietic cells. In conclusion, we provide evidence that CD4+ T lymphocytes expressing CD40L stimulate the Ab response to soluble caps-PS by interacting with CD40-expressing non-B cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
176
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
529-36
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16365447-Animals,
pubmed-meshheading:16365447-Antigen-Presenting Cells,
pubmed-meshheading:16365447-Antigens, CD40,
pubmed-meshheading:16365447-B-Lymphocytes,
pubmed-meshheading:16365447-Bacterial Capsules,
pubmed-meshheading:16365447-CD4-Positive T-Lymphocytes,
pubmed-meshheading:16365447-CD40 Ligand,
pubmed-meshheading:16365447-Cell Communication,
pubmed-meshheading:16365447-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:16365447-Immunoglobulin M,
pubmed-meshheading:16365447-Mice,
pubmed-meshheading:16365447-Mice, Inbred C57BL,
pubmed-meshheading:16365447-Mice, Knockout,
pubmed-meshheading:16365447-Mice, SCID,
pubmed-meshheading:16365447-Pneumococcal Infections,
pubmed-meshheading:16365447-Streptococcus pneumoniae
|
pubmed:year |
2006
|
pubmed:articleTitle |
CD4+ T lymphocytes expressing CD40 ligand help the IgM antibody response to soluble pneumococcal polysaccharides via an intermediate cell type.
|
pubmed:affiliation |
Laboratory of Experimental Laboratory Medicine, Department of Medical Diagnostic Sciences, Catholic University, Leuven Belgium.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|